{"id":"https://openalex.org/W1503091029","doi":null,"title":"A Potent Target for Cancer Treatment \u2013 Tumor Hypoxia Necrosis: An Overview","display_name":"A Potent Target for Cancer Treatment \u2013 Tumor Hypoxia Necrosis: An Overview","publication_year":2014,"publication_date":"2014-07-01","ids":{"openalex":"https://openalex.org/W1503091029","mag":"1503091029"},"language":"en","primary_location":{"id":"mag:1503091029","doi":null,"is_oa":false,"landing_page_url":"https://www.pharmatutor.org/pdf_download/pdf/Vol.%202,%20Issue%207,%20July%202014,%20PharmaTutor,%20Paper-1.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210228990","display_name":"Pharmatutor","issn_l":"2347-7881","issn":["2347-7881","2394-6679"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Pharmatutor","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102249823","display_name":"Pankaj Bajirao Patil","orcid":"https://orcid.org/0000-0001-5889-8595","observed_orcids":["https://orcid.org/0000-0001-5889-8595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pankaj Patil","raw_affiliation_strings":["Pharmaceutical sciences and technology, ICT"],"raw_orcid":"https://orcid.org/0000-0001-5889-8595","affiliations":[{"raw_affiliation_string":"Pharmaceutical sciences and technology, ICT","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010617070","display_name":"Raju Tayade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raju Tayade","raw_affiliation_strings":["Pharmaceutical sciences and technology, ICT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical sciences and technology, ICT","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"7","first_page":"8","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-1","display_name":"HIF-1","score":0.9340000152587891},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor","display_name":"hypoxia-inducible factor","score":0.7710000276565552},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5509999990463257},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.8159999847412109},{"id":"https://openalex.org/keywords/bioreductive-drugs","display_name":"bioreductive drugs","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/recombinant-bacteria","display_name":"recombinant bacteria","score":0.949999988079071},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6209999918937683},{"id":"https://openalex.org/keywords/radioresistance-biology","display_name":"radioresistance (biology)","score":0.7039999961853027},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.6779476404190063},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6350358724594116},{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.5884374380111694},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5088884830474854},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4839961528778076},{"id":"https://openalex.org/C31194975","wikidata":"https://www.wikidata.org/wiki/Q20970095","display_name":"HIF1A","level":3,"score":0.43853700160980225},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4381732940673828},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.4278355538845062},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.42638176679611206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3212158679962158},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28087174892425537},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27848151326179504},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2444244921207428},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20414769649505615},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.14315220713615417},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.13109594583511353},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1503091029","doi":null,"is_oa":false,"landing_page_url":"https://www.pharmatutor.org/pdf_download/pdf/Vol.%202,%20Issue%207,%20July%202014,%20PharmaTutor,%20Paper-1.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210228990","display_name":"Pharmatutor","issn_l":"2347-7881","issn":["2347-7881","2394-6679"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Pharmatutor","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1976880272","https://openalex.org/W1992906059","https://openalex.org/W1996830477","https://openalex.org/W2000156247","https://openalex.org/W2004262765","https://openalex.org/W2024903578","https://openalex.org/W2034822725","https://openalex.org/W2035565668","https://openalex.org/W2079174568","https://openalex.org/W2079906459","https://openalex.org/W2081427468","https://openalex.org/W2088715496","https://openalex.org/W2100053954","https://openalex.org/W2101521188","https://openalex.org/W2117064395","https://openalex.org/W2130396048","https://openalex.org/W2131464730","https://openalex.org/W2157000380","https://openalex.org/W2157908163","https://openalex.org/W2167510293"],"related_works":["https://openalex.org/W2168607632","https://openalex.org/W2018005037","https://openalex.org/W1996830477","https://openalex.org/W2509383355","https://openalex.org/W2413701238","https://openalex.org/W2088909352","https://openalex.org/W2088397778","https://openalex.org/W2150437708","https://openalex.org/W1602596933","https://openalex.org/W2035565668"],"abstract_inverted_index":{"Tumor":[0],"hypoxia":[1,74],"is":[2,34],"feature":[3],"of":[4,41,62,72],"locally":[5],"advancing":[6],"solid":[7,18],"tumor":[8,19,42,73,83],"and":[9,27,76,92],"also":[10],"considered":[11],"as":[12],"potential":[13],"therapeutic":[14],"challenge.":[15],"It":[16],"causes":[17],"resistible":[20],"to":[21],"the":[22,35,39],"cancer":[23],"treatment":[24,61,85],"like":[25],"radiation":[26],"chemotherapeutic":[28],"drugs.":[29],"The":[30],"transcription":[31],"factor":[32],"HIF-1":[33],"major":[36],"player":[37],"in":[38],"regulation":[40],"progression":[43],"into":[44],"malignant":[45],"phenotype.":[46],"We":[47],"can":[48],"target":[49],"this":[50],"hypoxic":[51,80],"conditions":[52],"using":[53],"pathophysiological":[54],"approach":[55],"for":[56,60,78],"targeted":[57],"drug":[58],"delivery":[59],"cancer.":[63],"This":[64,82],"review":[65],"will":[66,86],"focus":[67],"on":[68],"various":[69],"biological":[70],"aspects":[71],"necrosis":[75],"approaches":[77],"targeting":[79],"tumors.":[81],"selective":[84],"include":[87],"bioreductive":[88],"drugs,":[89],"gene":[90],"therapy,":[91],"recombinant":[93],"bacteria.":[94]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}